CITIGROUP INC - SUTRO BIOPHARMA INC ownership

SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 115 filers reported holding SUTRO BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of SUTRO BIOPHARMA INC
ValueSharesWeighting
Q3 2023$2,863
-96.8%
825
-95.7%
0.00%
Q2 2023$88,252
-88.9%
18,979
-89.0%
0.00%
-100.0%
Q1 2023$795,245
+125.3%
172,131
+293.9%
0.00%
Q4 2022$353,048
+4943.5%
43,694
+3271.5%
0.00%
Q3 2022$7,000
-66.7%
1,296
-67.1%
0.00%
Q2 2022$21,000
-91.1%
3,939
-86.3%
0.00%
Q1 2022$236,000
-78.2%
28,671
-60.7%
0.00%
-100.0%
Q4 2021$1,085,000
+35.1%
72,942
+71.6%
0.00%
Q3 2021$803,000
-68.6%
42,505
-69.1%
0.00%
-100.0%
Q2 2021$2,558,000
-33.7%
137,601
-18.9%
0.00%0.0%
Q1 2021$3,860,000
+255.8%
169,594
+239.4%
0.00%
+100.0%
Q4 2020$1,085,000
+8246.2%
49,971
+3913.7%
0.00%
Q3 2020$13,000
-23.5%
1,245
-44.0%
0.00%
Q2 2020$17,000
-45.2%
2,225
-27.5%
0.00%
Q1 2020$31,000
+29.2%
3,069
+40.7%
0.00%
Q4 2019$24,000
+166.7%
2,182
+119.7%
0.00%
Q3 2019$9,000
-71.9%
993
-64.9%
0.00%
Q2 2019$32,000
+68.4%
2,830
+66.2%
0.00%
Q1 2019$19,000
+18.8%
1,703
+1.1%
0.00%
Q4 2018$16,0001,6850.00%
Other shareholders
SUTRO BIOPHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 1,675,579$5,814,2591.78%
SUVRETTA CAPITAL MANAGEMENT, LLC 5,883,693$20,416,4151.10%
Kynam Capital Management, LP 1,552,675$5,387,7820.88%
Parkman Healthcare Partners LLC 1,182,168$4,102,1230.75%
Rubric Capital Management LP 3,344,810$11,606,4910.44%
BVF INC/IL 3,347,946$11,617,3730.31%
DAFNA Capital Management LLC 283,079$982,2840.31%
SECTORAL ASSET MANAGEMENT INC 432,339$1,500,2160.29%
Eversept Partners, LP 769,638$2,670,6440.23%
Frazier Life Sciences Management, L.P. 780,000$2,706,6000.18%
View complete list of SUTRO BIOPHARMA INC shareholders